Five breakthroughs. One platform. Powered by MIRA‑Cas12a. The CORDSv2 system developed in this study achieves five core advances: ✅ Extraction‑free nucleic acid processing ✅ Stable storage at ambient temperature ✅ One‑tube, one‑step operation ✅ Positive genotyping ✅ Portable fluorescence readout Performance? Highly consistent with laboratory gold‑standard qPCR. Built on MIRA‑Cas12a technology from AMP‑FUTURE BIOTECH — enabling rapid, field‑ready molecular detection without the constraints of traditional lab workflows. Transparency matters too. From a system‑boundary perspective, the method cannot identify naturally occurring deletion strains lacking the inserted eGFP/mCherry marker genes, and there's a small probability of missed detection for samples with extremely low viral loads (Ct > 36). No diagnostic platform is without limits — understanding them is part of advancing the field.
The CORDSv2 system developed in this study achieves five core advances:
✅ Extraction‑free nucleic acid processing
✅ Stable storage at ambient temperature
✅ One‑tube, one‑step operation
✅ Positive genotyping
✅ Portable fluorescence readout
Performance? Highly consistent with laboratory gold‑standard qPCR.
Built on MIRA‑Cas12a technology from AMP‑FUTURE BIOTECH — enabling rapid, field‑ready molecular detection without the constraints of traditional lab workflows.
Transparency matters too. From a system‑boundary perspective, the method cannot identify naturally occurring deletion strains lacking the inserted eGFP/mCherry marker genes, and there's a small probability of missed detection for samples with extremely low viral loads (Ct > 36). No diagnostic platform is without limits — understanding them is part of advancing the field.